Transgene Biotek fundamental analysis

TRABI

2.69

0.09 (-3.24%)
Last updated on 13 Jan, 2026 | 15:29 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Transgene Biotek Fundamentals

P/E Ratio

0

P/B Ratio

2.29

Div. Yield

0

Sector P/E

57.39

Sector P/B

-16.16

Sec. Div. Yield

2.29

Transgene Biotek Fundamentals is currently trading with a P/E Ratio of 0, compared to the sector average of 57.39. Its P/B Ratio stands at 2.29, while the sector’s is -16.16. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 2.29%.

Transgene Biotek Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Good

  • quality_check
    Quality

    Poor

  • quality_check
    Management

    Poor

On its scorecard, Transgene Biotek reflects: Price – Attractive, Growth – Good, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.